Assessment of the feasibility of oral controlled release in an exploratory development setting (Q36266989)

13 August 2017

1 reference

title

Assessment of the feasibility of oral controlled release in an exploratory development setting (English)

1 reference

13 August 2017

Avinash G Thombre

1

1 reference

13 August 2017

publication date

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

17

1 reference

13 August 2017

page(s)

1159-1166

1 reference

Role of the development scientist in compound lead selection and optimization

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

A comparison of physiochemical property profiles of development and marketed oral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Application of drug delivery technologies in lead candidate selection and optimization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

General pharmaceutics--the new physical pharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

The Biopharmaceutic Drug Classification and Drugs Administered in Extended Release (Er) Formulations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Dissolution and Absorption Modeling: Model Expansion to Simulate the Effects of Precipitation, Water Absorption, Longitudinally Changing Intestinal Permeability, and Controlled Release on Drug Absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Selection of solid dosage form composition through drug-excipient compatibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Companion animal physiology and dosage form performance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Human intestinal permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Prediction of human intestinal absorption of drug compounds from molecular structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Assessing the absorption of new pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Oral absorption of anti-aids nucleoside analogues: 3. Regional absorption and in vivo permeability of 2',3'-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Differential absorption of amoxicillin from the human small and large intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Development of a new engineering-based capsule for human drug absorption studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

The use of formulation technology to assess regional gastrointestinal drug absorption in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

The drug efflux-metabolism alliance: biochemical aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Intestinal drug efflux: formulation and food effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

P-glycoprotein increases from proximal to distal regions of human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Influence of Food Intake on Presystemic Clearance of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

A nomogram to predict the best biological half-life values for candidates for oral prolonged-release formulations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Osmotic drug delivery using swellable-core technology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903551-8

7 January 2021

10.1016/S1359-6446(05)03551-8

Identifiers

DOI

1 reference

13 August 2017

1 reference